Global Recombinant Human Insulin Market Growing at 5.6% CAGR Through 2034
According to a new report from Intel Market Research, the global Recombinant Human Insulin market was valued at USD 5.8 billion in 2025 and is projected to grow from USD 6.3 billion in 2026 to USD 9.7 billion by 2034, exhibiting a steady CAGR of 5.6% during the forecast period (2026–2034). This growth is driven by the rising prevalence of diabetes globally, advancements in...
0 Compartilhamentos
3 Visualizações